Martire G, Lovisa F, Carraro E, Rizzato D, et al. TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification. Haematologica 2024 Feb 22. doi: 10.3324/haematol.2023.284868.
PMID: 38385281